BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38920144)

  • 1. Improving management of AL amyloidosis.
    Lee YS; Huang J
    Ann Acad Med Singap; 2023 Nov; 52(11):559-560. PubMed ID: 38920144
    [No Abstract]   [Full Text] [Related]  

  • 2. Localized Lymph Node Light Chain Amyloidosis.
    Yamamoto A; Fujii N; Obika M; Yamashita T; Otsuka F
    Intern Med; 2020 Oct; 59(19):2415-2418. PubMed ID: 32611959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
    Hasib Sidiqi M; Gertz MA
    Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AL Amyloidosis].
    Ueda M
    Brain Nerve; 2024 May; 76(5):583-587. PubMed ID: 38741500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of systemic light chain AL amyloidosis.
    Bhutani D; Lentzsch S
    Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [To positively deal with the challenges brought by the diagnosis and treatment of systemic light chain amyloidosis].
    Huang XH; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(22):1631-1634. PubMed ID: 34126710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of Therapeutic Innovation.
    Dima D; Mazzoni S; Anwer F; Khouri J; Samaras C; Valent J; Williams L
    JCO Oncol Pract; 2023 May; 19(5):265-275. PubMed ID: 36854070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supportive Care in AL Amyloidosis.
    Cibeira MT; Ortiz-Pérez JT; Quintana LF; Fernádez de Larrea C; Tovar N; Bladé J
    Acta Haematol; 2020; 143(4):335-342. PubMed ID: 32235118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management.
    Baumgart JV; Stuhlmann-Laeisz C; Hegenbart U; Nattenmüller J; Schönland S; Krüger S; Behrens HM; Röcken C
    Virchows Arch; 2018 Nov; 473(5):627-637. PubMed ID: 30136180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.
    Gertz MA
    Blood Cancer J; 2018 May; 8(5):44. PubMed ID: 29795248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the elderly patient with AL amyloidosis.
    Nuvolone M; Milani P; Palladini G; Merlini G
    Eur J Intern Med; 2018 Dec; 58():48-56. PubMed ID: 29801808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis.
    Acevedo J; Doros G; Szalat R; Sanchorawala V
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):425-426. PubMed ID: 33622658
    [No Abstract]   [Full Text] [Related]  

  • 14. When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression.
    Palladini G; Merlini G
    Blood Adv; 2019 Jan; 3(2):212-215. PubMed ID: 30670537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details.
    Sanchorawala V
    Blood Adv; 2019 Jan; 3(2):216-218. PubMed ID: 30670538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Nervous System Involvement.
    Thaisetthawatkul P; Dyck PJB
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1091-1098. PubMed ID: 33099426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment.
    Cherico AS; Rizvi A; Jayakrishnan T; Mewawalla P
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35817492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized Approach to Management of Light Chain Amyloidosis.
    Palladini G; Milani P
    J Natl Compr Canc Netw; 2023 Jan; 21(1):91-98. PubMed ID: 36634608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
    Muchtar E; Dispenzieri A; Gertz MA; Kumar SK; Buadi FK; Leung N; Lacy MQ; Dingli D; Ailawadhi S; Bergsagel PL; Fonseca R; Hayman SR; Kapoor P; Grogan M; Abou Ezzeddine OF; Rosenthal JL; Mauermann M; Siddiqui M; Gonsalves WI; Kourelis TV; Larsen JT; Reeder CB; Warsame R; Go RS; Murray DL; McPhail ED; Dasari S; Jevremovic D; Kyle RA; Lin Y; Lust JA; Russell SJ; Hwa YL; Fonder AL; Hobbs MA; Rajkumar SV; Roy V; Sher T
    Mayo Clin Proc; 2021 Jun; 96(6):1546-1577. PubMed ID: 34088417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonchemotherapy Treatment of Immunoglobulin Light Chain Amyloidosis.
    Van Doren L; Lentzsch S
    Acta Haematol; 2020; 143(4):373-380. PubMed ID: 32526750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.